Aspire Biopharma Holdings, Inc. filed a Certificate of Amendment to change its name to Aspire-Lakewood Holdings, Inc., effective September 8, 2026, with no stockholder approval required and the trading symbol remaining ASBP. Concurrently, the Board authorized an expanded $10 million common stock repurchase program effective September 9, 2026, citing strong free cash flow generation from its acquisition of Dura Control Systems Corp (DCSC). DCSC contributed approximately $209.5 million in revenue and $22.3 million in Adjusted EBITDA for the full year 2025, supporting management's view that the share price does not reflect the company's financial strength. The repurchase program has no expiration date and may be suspended at any time. Aspire-Lakewood Holdings operates as a holding company with subsidiaries in automotive control systems and biopharmaceutical development.
